HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Functional Beverages Stimulate Natural Products Market Growth - Analysts

This article was originally published in The Tan Sheet

Executive Summary

The natural products market, fueled by nutritionally fortified foods such as functional beverages, meal replacement bars and soy products, will continue to demonstrate strong annual growth in the mid-teens over the next several years, analysts predict.

You may also be interested in...



Metabolife Ephedra-Free Snack Bars Will Target Consumers With Sampling

Metabolife International's $2.4 mil. product sampling effort for its new nutrition bars will include co-packaging the bars with the company's flagship Metabolife 356 product

Quaker/PepsiCo

Merger completion near as FTC votes to end investigation into potential anti-competitive issues, firms announce Aug. 1. Dissenting Commissioners Sheila Anthony and Mozelle Thompson term decision "regrettable," express concerns about united Gatorade and Pepsi marketer's influence on stratified soft drink industry while Commissioners Orson Swindle and Thomas Leary note FTC can "address actual conduct" if objectionable actions are taken by new entity. PepsiCo agreed to acquire Quaker Oats in December in a deal valued at $13.4 bil. (1"The Tan Sheet" Dec. 11, 2000, p. 4)

United Therapeutics Cooke Pharma Buyout Provides Added Marketing/R&D

United Therapeutics Corporation's acquisition of Cooke Pharma will give the HeartBar manufacturer a boost in marketing and research and development resources.

Related Content

Topics

UsernamePublicRestriction

Register

SC142283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel